Newcastle upon Tyne Hospitals NHS Foundation Trust
Novo Nordisk
China Scholarship Council
Shanghai Jiao Tong University
Zhejiang Shuren University
Otsuka Pharmaceutical
Pusan National University Hospital
Nagoya City University
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Uniwersytet Śląski w Katowicach
Instituto de Investigación Marqués de Valdecilla
Ruijin Hospital
University of California, Davis
Chugai Pharmaceutical
Cumming School of Medicine, University of Calgary
NIHR Newcastle Biomedical Research Centre
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
Joaquín Cabezas, Melanie Paff, Yasuhito Tanaka, Sébastien Poulin et al.
Citations
41 citations
Journal
Journal of Hepatology
Topics
Hepatitis B Virus Studies
Field-Weighted Citation Impact (FWCI)
15.85
article
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
Joaquín Cabezas, Melanie Paff, Yasuhito Tanaka, Sébastien Poulin, Natalya Gankina, Amir S. Youssef, Thomas G. Greene, Maximilian Lee, Hyung Joon Yim, Kei Fujiwara, Pablo Ryan, Susan Dixon, Jeong Heo, Stuart C. Gordon, Eric Chak, Olga Sagalova, Ewa Janczewska, Stuart Kendrick, Stuart McPherson, Pietro Andreoné, Rob Elston, Dickens Theodore, Masanori Atsukawa, Jessica Lim, Atsumasa Komori, Carla S. Coffin, Divya Lakshminarayanan, Robert Pleśniak, Qing Xie, Maria Buti, Guoping Sheng, Grant McGonagle, Pietro Lampertico, Vyacheslav Morozov, Natalya Voloshina, Helene Plein, Leigh Felton
article en
41 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of HepatologyVol. 82(2)
Institutions
University of Modena and Reggio Emilia (IT), Medical University of Silesia (PL), University of Calgary (CA), Shanghai Jiao Tong University (CN), Wayne State University (US), University of Milan (IT), Korea University (KR), Age UK (GB), Instituto de Salud Carlos III (ES), Ruijin Hospital (CN), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Freeman Hospital (GB), Chelyabinsk State Medical Academy (RU), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Ansan University (KR), Ospedale Maggiore (IT), Marqués de Valdecilla University Hospital (ES), Instituto de Investigación Marqués de Valdecilla (ES), GlaxoSmithKline (United States) (US), Regional Center for Prevention and Control of AIDS and Infectious Diseases (RU), Nagoya City University Hospital (JP), Pusan National University Hospital (KR), Nagasaki Medical Center (JP), Kumamoto University Hospital (JP), Vall d'Hebron Hospital Universitari (ES), Zhejiang Shuren University (CN), NIHR Newcastle Biomedical Research Centre (GB), Nippon Medical School Hospital (JP), Hospital Universitario Infanta Leonor (ES), Pusan National University (KR), University of California, Davis (US), University of Rzeszów (PL)
Funders
Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Gilead Sciences, Alnylam Pharmaceuticals, Wayne State University, Università degli Studi di Milano, Kowa Company, Kaken Pharmaceutical, Yuhan, GlaxoSmithKline España, National Institute for Health and Care Research, Pusan National University, Korea University, Newcastle upon Tyne Hospitals NHS Foundation Trust, Novo Nordisk, China Scholarship Council, Shanghai Jiao Tong University, Zhejiang Shuren University, Otsuka Pharmaceutical, Pusan National University Hospital, Nagoya City University, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Uniwersytet Śląski w Katowicach, Instituto de Investigación Marqués de Valdecilla, Ruijin Hospital, University of California, Davis, Chugai Pharmaceutical, Cumming School of Medicine, University of Calgary, NIHR Newcastle Biomedical Research Centre